EUVIMEDEUVIMED entdecken
Crossref

Clinical value of plasma p-tau217 in identifying mild cognitive impairment due to Alzheimer's disease: A comparative multimarker analysis

Xiaocong Guo iD, Yue Liu, Zilin Wang, Xiaoya Xu

Journal of Alzheimer’s Disease · 20.11.2026

DOI: 10.1177/13872877261507291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 20.11.2026. Verfasst von Xiaocong Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Zigong First People's Hospital, Zigong, China. Die Arbeit nennt 44 Literaturangaben. Gefördert von: ZiGong Science and Technology Bureau, Medical Research Project of Sichuan Medical Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD) causes progressive neurodegeneration, and mild cognitive impairment due to AD (AD-MCI) represents a critical window for intervention. Invasive or costly diagnostic tools hinder early detection. The 2024 NIA-AA criteria recognize plasma p-tau217 as a core blood-based biomarker for prodromal AD, supporting the clinical translation of peripheral pathological markers.

Objective

To compare plasma biomarker profiles between AD-MCI and cognitively unimpaired (CU) participants, evaluate the diagnostic performance of p-tau217, p-tau181, and Aβ 42 /Aβ 40 ratio for detecting this AD-MCI group, and assess correlations between these plasma biomarkers and cognitive function in the cohort.

Methods

Fifty-one participants were enrolled from a single center in China. Plasma p-tau217, p-tau181, and the Aβ 42 /Aβ 40 ratio were measured using a domestically developed fluorescent magnetic-particle immunoassay (FMIA). ROC curve analysis was used to assess diagnostic performance, and Spearman correlation analysis was used to test biomarker-cognition associations.

Results

Plasma p-tau217 yielded the highest AUC = 0.923 (cut-off: 4.35 pg/mL; sensitivity 80.9%; specificity 96.6%), outperforming p-tau181 (AUC = 0.902) and the Aβ 42 /Aβ 40 ratio (AUC = 0.714). Only weak, non-significant correlations were observed between biomarkers and cognitive scores in the AD-MCI group (r ranged from −0.22 to 0.05).

Conclusions

Plasma p-tau217 measured using this FMIA showed excellent diagnostic performance for AD-MCI in a cohort from southwestern China. The population- and platform-specific cut-offs differed from those reported in Western cohorts using Simoa-based assays. Weak cognitive correlations suggest that plasma p-tau217 primarily reflects brain amyloid and tau pathology rather than cognitive severity, supporting its use for community-based triage screening for early AD.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseblood biomarkerearly diagnosismild cognitive impairmentphosphorylated tau217

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Zigong First People's Hospital, Zigong, China.
  • Department of Neurology, Zigong First People's Hospital, Zigong, China.

ORCID-Profile: Xiaocong Guo

Förderung

  • ZiGong Science and Technology Bureau
  • Medical Research Project of Sichuan Medical Association

Zitieren

APA

Guo, X., Liu, Y., Wang, Z., & Xu, X. (2026). Clinical value of plasma p-tau217 in identifying mild cognitive impairment due to Alzheimer's disease: A comparative multimarker analysis. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261507291

Vancouver

Guo X, Liu Y, Wang Z, Xu X. Clinical value of plasma p-tau217 in identifying mild cognitive impairment due to Alzheimer's disease: A comparative multimarker analysis. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261507291

BibTeX
@article{Guo2026,
  author = {Guo, Xiaocong and Liu, Yue and Wang, Zilin and Xu, Xiaoya},
  title = {Clinical value of plasma p-tau217 in identifying mild cognitive impairment due to Alzheimer's disease: A comparative multimarker analysis},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877261507291}
}
Kostenlos starten →